Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
16 Sep 24 | CCCC C4 Therapeutics | Common Stock | Payment of exercise | Dispose F | No | No | 6.36 | 661 | 4.20 k | 130,710 |
16 Sep 24 | CCCC C4 Therapeutics | Common Stock | Option exercise | Acquire M | No | No | 0 | 2,250 | 0.00 | 131,371 |
16 Sep 24 | CCCC C4 Therapeutics | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 2,250 | 0.00 | 14,250 |
7 Mar 24 | CCCC C4 Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 19 | 118,000 | 2.24 mm | 118,000 |
7 Mar 24 | CCCC C4 Therapeutics | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 22.71 | 118,000 | 2.68 mm | 0 |
7 Mar 24 | CCCC C4 Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 19 | 94,950 | 1.80 mm | 94,950 |
7 Mar 24 | CCCC C4 Therapeutics | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 45.54 | 94,950 | 4.32 mm | 0 |
14 Feb 24 | CCCC C4 Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 27,300 | 0.00 | 129,121 |
14 Feb 24 | CCCC C4 Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 7.31 | 122,800 | 897.67 k | 122,800 |
13 Feb 24 | CCCC C4 Therapeutics | Common Stock | Payment of exercise | Dispose F | No | No | 6.53 | 2,255 | 14.73 k | 101,821 |